Abstract

In China, H9N2 avian influenza virus (AIV) has become widely prevalent in poultry, causing huge economic losses after secondary infection with other pathogens. Importantly, H9N2 AIV continuously infects humans, and its six internal genes frequently reassort with other influenza viruses to generate novel influenza viruses that infect humans, threatening public health. Inactivated whole-virus vaccines have been used to control H9N2 AIV in China for more than 20 years, and they can alleviate clinical symptoms after immunization, greatly reducing economic losses. However, H9N2 AIVs can still be isolated from immunized chickens and have recently become the main epidemic subtype. A more effective vaccine prevention strategy might be able to address the current situation. Herein, we analyze the current status and vaccination strategy against H9N2 AIV and summarize the progress in vaccine development to provide insight for better H9N2 prevention and control.

MeSH

Vaccines, Vaccination, Signs And Symptoms, Influenza, Human, Viruses, Orthomyxoviridae

Cited by

• Bursal-Derived BP7 Induces the miRNA Molecular Basis of Chicken Macrophages and Promotes the Differentiation of B Cells. Vaccines (Basel), 2022
• Characterization of H9N2 avian influenza virus isolated from chickens and waterfowl in parts of Southern China from 2018 to April 2024. Poult Sci, 2025
• The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China. Lancet Reg Health West Pac, 2023
• Enhanced Immunogenicity of Chicken H9N2 Influenza Inactivated Vaccine Through a Novel Dual-Targeting Fusion Protein Strategy. Vaccines (Basel), 2025
• Construction of a replication-defective recombinant virus and cell-based vaccine for H9N2 avian influenza virus. Vet Res, 2025
• Proposal for a Global Classification and Nomenclature System for A/H9 Influenza Viruses. Emerg Infect Dis, 2024
• Epidemiology and evolutionary dynamics of H9N2 avian influenza virus in Bangladesh. Emerg Microbes Infect, 2025
• Molecular patterns of matrix protein 1 (M1): A strong predictor of adaptive evolution in H9N2 avian influenza viruses. Proc Natl Acad Sci U S A, 2025
• Development of an experimental model using cold stress to assess the pathogenicity of two Moroccan AI H9N2 isolates from 2016 and 2022 in commercial broiler chickens. PLoS One, 2025
• Evolutionary Events Promoted Polymerase Activity of H13N8 Avian Influenza Virus. Viruses, 2024
• The Chinese Hamster Ovary Cell-Based H9 HA Subunit Avian Influenza Vaccine Provides Complete Protection against the H9N2 Virus Challenge in Chickens. Viruses, 2024
• Pathogenicity of Novel H3 Avian Influenza Viruses in Chickens and Development of a Promising Vaccine. Viruses, 2025
• H9 Consensus Hemagglutinin Subunit Vaccine with Adjuvants Induces Robust Mucosal and Systemic Immune Responses in Mice by Intranasal Administration. Microorganisms, 2024
• Spray vaccination with a safe and bivalent H9N2 recombinant chimeric NDV vector vaccine elicits complete protection against NDV and H9N2 AIV challenge. Vet Res, 2025
• Recombinant avian metapneumovirus subtype C expressing HA protein of H9N2 avian influenza virus are stable and induce protection. Front Microbiol, 2025